← Master Registry

Published peptide research references

Polymyxin B

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Clinical Use of Polymyxin B.

    DOI: 10.1007/978-3-030-16373-0_14

    Source identity and connection checked by Codex (AI).

  2. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial.

    DOI: 10.1016/s2213-2600(26)00047-0

    Source identity and connection checked by Codex (AI).

  3. Polymyxin B-induced skin hyperpigmentation.

    DOI: 10.1111/tid.13312

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Rigatto MH
  • Falci DR
  • Zavascki AP
  • Neyra JA
  • Legrand M
  • Tidswell MA
  • Al-Khafaji A
  • Galphin C
  • Rains R
  • Davison D
  • Tolwani A
  • Chen JT
  • Bender WS
  • Busse LW
  • Meena NK
  • DellaVolpe J
  • Williams GW
  • Kashani KB
  • Gunnerson KJ
  • McMahon BA
  • Eaton J
  • Khan S
  • Kohli-Seth R
  • Jagpal S
  • Klein D
  • Kamaluddin E
  • Foster DM
  • Walker PM
  • Tomlinson G
  • Kellum JA
  • Li YM
  • Milikowski C
  • Selvaggi G
  • Abbo LM
  • Skiada D
  • Galimberti F
  • Dellinger RP
  • Bagshaw SM
  • Antonelli M
  • Klein DJ
  • Marshall JC
  • Palevsky PM
  • Weisberg LS
  • Schorr CA
  • Trzeciak S
  • EUPHRATES Trial Investigators